Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

miR-155 levels in blood could help identify alopecia areata.

AI-assisted surgical robots improve surgery precision and safety.

The AI model DIET-AI effectively diagnoses skin diseases as well as doctors.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Researchers found a new mutation in the HR gene linked to a rare hair loss condition.

Children with alopecia areata and their caregivers experience significant emotional and quality of life challenges.

Autoimmune diseases need combined therapy of tolerance induction and immunosuppression.

Minoxidil can reduce functions related to androgen receptors.

The treatment cleared psoriasis in some patients but caused side effects in most.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Vitamin D receptor mutations can cause alopecia by affecting hair growth genes.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Brentuximab vedotin chemotherapy can cause long-term hair loss and emotional distress.

Anti-SRP myopathy can be linked to systemic lupus erythematosus and may improve with specific treatment.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

Low-dose oral minoxidil and finasteride effectively improve hair growth in men with androgenetic alopecia.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.